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• Depression is one of the 10 research priorities in stroke aphasia (Franklin
et al., 2018). In fact, around 40 % of persons with aphasia (PWA) develop
apathy and depression after stroke.
• Until recently there was no information on the treatment of apathy and
depression in PWA. In this line, Mohr et al. (2017) have found that
intensive language-action therapy (ILAT) reduces symptoms of depression
in PWA, but the neural correlates of such improvement remain
unexplored.
• ILAT is a group language therapy that follows massed practice and action-
embedded language use that may be useful for daily live (Difrancesco,
Pulvermuller and Mohr, 2012). The behavioral improvements associated
to ILAT can be potentiated when applied in combination to cognitive-
enhacement drugs such as the cholinesterase inhibitor donepezil (DP)
(Berthier, 2006, 2003).
BACKGROUND
AIMS
• To explore the neural underpinnings of improvements in apathy and 
depression associated to DP alone and combined with ILAT.
METHODS
• Participants: 10 persons with post-stroke chronic (> 6 months) aphasia (8 
men; mean age: 51.8 (SD 5.71).
• Study design: 10-week open-label pilot study 
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• Primary outcome measures: Western Aphasia Battery (WAB), the
Communicative Activity Log (CAL), the Stroke Aphasic Depression
Questionnaire (SADQ) and the Stroke and Aphasia Quality of Life Scale-39
(SAQOL-39). The severity of apathy and depression were measured with
different items from the SADQ.
• Neuroimaging evaluation: Structural MRI and [18]fluorodeoxyglucose PET
(18FDG-PET) were acquired at weeks 0, 8 and 10.
• Neuroimaging analyses: Voxel-based morphometry (VBM) with a p < 0.001
(uncorrected; threshold: 50) was used. For 18FDG-PET the correlation
between signal differences at each ROI and the differences in each of the
subscales of the SADQ (apathy and depression) were studied.
• In conclusion, treatment with DP alone and combined with ILAT
improved aphasia, communication and quality of life as well as
associated apathy and depression by modulating regions innervated
by the left medial, right lateral and brainstem cholinergic pathways.
• Behavioral results showed improvements with DP alone and under
DP-ILAT in AQ-WAB, CAL and SAQoL-39. 18FDG-PET analysis revealed
that DP alone induced significant increments in metabolic activity in
the ventral tegmental area (VTA), left anterior cingulate cortex (ACC)
and right superior temporal gyrus that were correlated with
improvement in apathy. Although depression improved there were no
metabolic changes under DP alone. However, reduction in depressive
symptoms under DP-ILAT showed increased metabolic activity
(compared to baseline) in the VTA, right ACC, left and right middle
temporal gyrus, left and right inferior frontal operculum and
orbitofrontal cortex.
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CONCLUSIONS
• The VBM analysis revealed that DP alone treatment induced increases in
grey matter density in the cuneus and right deep frontal operculum-
anterior insula region associated to improvements in apathy and in right
intraparietal sulcus associated to improvements in depression. Combined
DP-ILAT improved apathy and induced changes in the right ventral striatum
and right cerebellum compared with baseline (see figure). Conjoint
analysis of PSA and PSD disclosed increases in grey matter density in the
left middle cingulum .
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